The ATLANTIC study, involving several centers in Portugal and Spain, is the first study evaluating the safety and efficacy of intravitreal injections (namely aflibercept) as a treatment for polypoidal choroidal vasculopathy (PCV) in a Caucasian population. Rufino Silva, MD, PhD, principal investigator, briefly presents the study.

Related Articles